CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.) - ES 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:800-900

Ranking timeline:

Project Participation Performance(2020-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 13
As coordinator: 2
As participant: 5
Sole participant: 6
Coordinator / Participant Ratio: 0.4*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 181.153 0 181.153 1
2021 10.330.753 20.498.527 6.886.777 5 2
2020 8.170.122 24.969.701 2.881.627 2 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ2
SOCIETE EUROPEENNE DE CARDIOLOGIE2
UNIVERSITEIT MAASTRICHT2
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
CARISTO DIAGNOSTICS LIMITED1
CENTRE INTEGRE UNIVERSITAIRE DE SANTE ET DE SERVICES SOCIAUX DE L ESTRIECENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE1
CENTRE REGIONAL DE LUTTE CONTRE LE CANCER HENRI BECQUEREL ROUEN1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CENTRUM MEDYCZNE KSZTALCENIA PODYPLOMOWEGO1
CLALIT HEALTH SERVICES1
DEUTSCHES PRIMATENZENTRUM1
ETHRIS1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FAKULTNI NEMOCNICE KRALOVSKE VINOHRADY1
FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANON1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL1
FUNDACION PUBLICA ANDALUZA PARA LAGESTION DE LA INVESTIGACION EN SALUD DE SEVILLA1
GLSMED LEARNING HEALTH1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE1
IDOVEN 1903 SL1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
IMT TRANSFERT1
INSERM TRANSFERT1
INST CARDIOMETABOLISME NUTRITION ICAN1
INSTITUT CATALA D'ONCOLOGIA1
INSTITUT GUSTAVE ROUSSY1
INSTITUTO PORTUGUES DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL EPE1
IRCCS OSPEDALE POLICLINICO SAN MARTINO1
KING'S COLLEGE LONDON1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
KOMPETENZNETZ VORHOFFLIMMERN EV1
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW1
LAKKA HEALTH OY1
LAKKA TECHNOLOGIES OY1
LVIVSKYI NATIONALNYI MEDYCHNYI UNIVERSYTET IMENI DANYLA HALYTSKOHO1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
OPTIMAPHARM NORDIC OY1
OULUN YLIOPISTO1
OWKIN FRANCE1
PAPWORTH HOSPITAL NHS FOUNDATION TRUST1
PHILIPS IBERICA1
PHILIPS MEDICAL SYSTEMS NEDERLAND BV1
PREVENTICUS1
PRONOXIS AB1
REDOXIS AB1
REGION UPPSALA1
RUPRECHT KARLS UNIVERSITAET HEIDELBERG1
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANT'ANNA1
SIEMENS1
SORBONNE UNIVERSITE1
ST VINCENZKRANKENHAUS1
SWANSEA UNIVERSITY1
SYNLAB HOLDING DEUTSCHLAND1
TAMPEREEN AMMATTIKORKEAKOULU OY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE GENERAL HOSPITAL CORPORATION1
THE UNIVERSITY OF SHEFFIELD1
UNIVERSITAET BERN1
UNIVERSITAET ZU LUEBECK1
UNIVERSITAETSKLINIKUM ESSEN1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN1
UNIVERSITEIT HASSELT1
UNIVERSITY OF AARHUS1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF SURREY1
UNIVERSITY OF TAMPERE1
UNIWEB1
UNIWEB SIA1
UNIWERSYTET JAGIELLONSKI1
WEIZMANN INSTITUTE OF SCIENCE1
YOURRHYTHMICS1
ZECLINICS SL1
ZORA BIOSCIENCES OY1

Constancy:

Total number of partners: 95
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 92
Frequent / Rare Partner Ratio: 0.03

Project overview:

Start dateProjectacronymrolefundingpartners
2022-05-01DecIphering nucLEar Mechanics in diabetes: a Multi-scAle perspective DILEMMAcoordinator181.1531
2021-11-01Functional relevance of mitochondrial supercomplex assembly in myeloid cells MY MITOCOMPLEXcoordinator172.9321
2021-07-01STING signalling modulation via the Electron Transport Chain STIMULATEcoordinator160.9321
2021-06-01Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. RESILIENCEcoordinator5.998.38818
2021-06-01Uncovering Protein Mechanics in Physiology and Disease ProtMechanics-Livecoordinator2.000.0001
2021-06-01Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial RITA-MI 2participant6.583.21614
2021-03-01Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation MAESTRIAparticipant13.915.31120
2021-03-01Understanding and modulating vascular arrest with ultra-high definition AngioUnrestUHDcoordinator1.998.5001
2020-08-01EXpansion and Phenotype Loss Of SMCs In Atherosclerosis: Causal effects and therapeutic possibilities EXPLOSIAparticipant1.998.8752
2020-02-01Progeria models to study endothelial cell ageing: implications for organ regeneration and fibrosis EnCAgecoordinator170.1221
2020-01-01New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms REANIMAcoordinator8.000.00012
2020-01-01Personalized Prevention for Coronary Heart Disease CoroPreventionparticipant19.970.82724
2020-01-01Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. NeutroCureparticipant2.999.99912